期刊文献+

口服轮状病毒活疫苗的社区应用效果评价 被引量:12

Study on the Effectiveness of Rotavirus Vaccine for Oral Use to Prevent Diarrhea in the Community
下载PDF
导出
摘要 目的探讨口服轮状病毒活疫苗在社区卫生服务中的应用效果,以提高预防接种率,促进社区卫生服务疾病预防工作。方法将在社区健康服务中心建立健康档案的2000名6月龄~3周岁的儿童随机分成服苗组和对照组,进行轮状病毒腹泻的发病情况比较。结果服苗组发病率为2.1%,同期对照组的发病率为8.4%,两者差异有统计学意义(P<0.01),且服苗组的发病程度明显低于对照组。结论口服轮状病毒活疫苗预防儿童轮状病毒腹泻效果显著。 OBJECTIVE To explore the effectiveness of rotavirus vaccine for oral use to prevent diarrhea of the children and provide the scientific base for prevention of diarrhea. METHODS A community test was designed, in which Cases were children who were from 6- monthes to 3-years old, and accept rotavirus vaccine for oral use in Shenzhen City in 2000, and the controls were chosen by random from the children who were unwilling to take the vaccine. RESULTS The diarrhea incidence of case group was 2.1%, and the control group was 8.4%, and the difference has statistical significance(P〈0.01). CONCLUSION This study showed that the rotavirus vaccine for oral use had highly effective in preventing diarrhea in the children.
出处 《中国初级卫生保健》 2010年第6期24-25,共2页 Chinese Primary Health Care
基金 深圳市宝安区科技局(BAKJ2009473)
关键词 口服轮状病毒活疫苗 轮状病毒腹泻 社区卫生服务 rotavirus vaccine for oral use rotavirus diarrhea community health service
  • 相关文献

参考文献6

  • 1Parashar UD,Hummelman EG,Breaace J S,et al. Global illness and deaths caused by rotavirus discase in children[J]. Emerg Infect Dia, 2003, 9(5) : 565-572.
  • 2戌小平 江莲 杜玉春.医院内轮状病毒感染调查分析[J].中华医院感染学杂志,2000,10(2):131-131.
  • 3伍曼仪 陈觉凝 廖国仪 等.小儿腹泻病临床分析[J].广东医药,1996,17(9):588-588.
  • 4叶新华,金玉(综进),方肇寅(审校).轮状病毒腹泻的社会负担及疫苗的研究进展[J].国际病毒学杂志,2006,13(4):108-112. 被引量:22
  • 5李东,国泰,杨晓明.轮状病毒疫苗的研究现状[J].中国生物制品学杂志,2007,20(11):863-865. 被引量:10
  • 6Conmer ME,Graham DY, Eates MK.Determination of the duration of a primary immune response and the ID50 of ALA rabbit rotavirus in rabbits[J]. Arch Virol,1997(142): 2281-2294.

二级参考文献18

  • 1白植生.轮状病毒疫苗[M].张延龄,张晖主编.疫苗学.北京:科学出版社,2004:1351-1362.
  • 2Parashar UD,Hummelman EG,Breasee J S,et al.Global illness and deaths caused by rotavirus disease in children.Emerg Infect Dis,2003,9(5):565-572.
  • 3Conner ME,Graham DY,Estes MK.Determination of the duration of a primary immune response and the ID50 of ALA rabbit rotavirus in rabbits.Arch Virol,1997,142:2281-2294.
  • 4Anonymous.Withdrawal of rotavrus vaccine recommendation MMWR Morb Mortal Wkly Rep,1999,48(43):1007.
  • 5Zhou W,Pool V,Iskander J K,et al.Surveillance for safety after immunization:vaccine adverse event reporting system-United States 1991-2001.Pediatrics,2002,110(6):e67.
  • 6Murphy BR,Morens DM,Simonsen L,et al.Reappraisal of the association of intussusception with the licensed live rotavirus vaccine challenges initial conclusions.J Infect Dis,2003,187(8):1301-1308.
  • 7Bernstein DI,Sack DA,Reisinger K,et al.Second-year follow-up evaluation of live,attenuated human rotavirus vaccine 89-12 in healthy infants.J Infect Dis,2002,186(10):1487-1489.
  • 8Ruiz-Palacios GM,Perez-Schael I,Velazyuez FR,et al.Safety and Efficacy of an attenuated vaccine against severe rotavirus gastroenteritis.N Engl JV Med,2006,354(1):11-22.
  • 9Vesikari T,Matson Do,Dennehy P,et al.Safety and efficacy of a pentavalent human-bovine(WC3) reassortant rotavirus vaccine.N Engl J Med,2006,354(1):23-33.
  • 10Midthum K,hoshino Y,Kapikian AZ,et al.Single gene substitution rotavirus reassortants containing the major neutralization protein (VP7) of human rotavirus serotype 4.J Clin Microbiol,1986,24(5):822-826.

共引文献29

同被引文献97

引证文献12

二级引证文献79

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部